Symptoms & Early Warning Signs
Common indicators and clinical warning signs
Note: These symptoms are common and often caused by other conditions. However, if they persist for more than 2-3 weeks, especially if new or unusual, see a doctor. Early-stage ovarian cancer often has no symptoms.
Diagnosis Pathway
Step-by-step clinical evaluation and staging workflow
Medical history and physical examination (including pelvic exam)
CA-125 blood test (tumor marker)
Pelvic ultrasound or transvaginal ultrasound
CT scan or MRI of abdomen and pelvis
Surgery (laparoscopy or laparotomy) for biopsy and staging
Pathology report and staging
Genetic testing (BRCA1/BRCA2) if indicated
Staging Explained
How tumor size, lymph node involvement, and metastasis are graded
Cancer confined to one or both ovaries
Cancer spread to other pelvic organs (uterus, fallopian tubes, bladder, rectum)
Cancer spread to abdominal lining or lymph nodes
Metastatic (spread to distant organs like liver, lungs)
Treatment Options
Standard of care modalities according to NCCN clinical guidelines
Surgery
Primary treatment. Includes hysterectomy (removal of uterus), bilateral salpingo-oophorectomy (removal of both ovaries and fallopian tubes), and debulking (removal of as much tumor as possible). May include removal of lymph nodes and omentum.
Chemotherapy
Almost always used, either after surgery (adjuvant) or before surgery (neoadjuvant) for advanced disease. Common regimen: carboplatin + paclitaxel. Usually 6 cycles over 4-6 months.
Targeted Therapy
PARP inhibitors (olaparib, niraparib, rucaparib) for BRCA-mutated or HRD-positive ovarian cancer. Bevacizumab may be used with chemotherapy for advanced disease.
Hormone Therapy
For certain types of ovarian cancer (stromal tumors). Less common for epithelial ovarian cancer.
Radiation Therapy
Less commonly used for ovarian cancer. May be used for specific situations or palliative care.
Maintenance Therapy
PARP inhibitors or bevacizumab may be continued after initial treatment to prevent recurrence.
Treatment Cost Comparisons
Transparent out-of-pocket benchmarks for India and US healthcare centers
Treatment Cost in India
- CA-125 test: ₹500 - ₹2,000
- Ultrasound: ₹1,000 - ₹3,000
- Surgery (hysterectomy + debulking): ₹3-10 lakhs
- Chemotherapy (per cycle): ₹25,000 - ₹1,50,000
- Targeted therapy (PARP inhibitors): ₹80,000 - ₹4 lakhs per month
- Complete treatment: ₹8-30 lakhs (depending on stage and type)
Treatment Cost in US
- CA-125 test: $50 - $200
- Ultrasound: $200 - $500
- Surgery: $25,000 - $80,000
- Chemotherapy: $15,000 - $200,000 (depending on duration)
- Targeted therapy (PARP inhibitors): $10,000 - $20,000 per month
- Complete treatment: $60,000 - $300,000+
Frequently Asked Questions about Ovarian Cancer
This guide provides verified clinical insights based on established oncological literature (NCCN, ASCO, ESMO). It is not a substitute for professional medical diagnosis or personalized treatment planning. Always consult your qualified oncology specialist before initiating treatment.